Pharmacy Times

JUNE 27, 2023

Drug shortages are a common issue in the health care industry. Florida Cancer Specialists & Research Institute (FCS) is highly skilled at proactively managing the drug supplies it needs to care for patients.

Chemotherapy 94

Chemotherapy Patient Care 94

STAT

DECEMBER 22, 2023

“I do not believe this particular change will have any bearing on patient care,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti.

Labelling 125

Labelling Chemotherapy FDA Patient Care 125

Hospital Pharmacy Europe

DECEMBER 18, 2023

In this heterogeneous patient group, decisions on therapies and management must follow a multidimensional approach, integrating medical, socio-economic and psychological factors. Drug classes known to cause falls are commonly used in older patients , but cancer treatment can further increase this risk.

Chemotherapy 96

Chemotherapy Hospitals Labelling Communication 96

pharmaphorum

SEPTEMBER 25, 2020

Furthermore, the duration of response with the PD-1 checkpoint inhibitor was nearly five times longer at 29 months versus just over six months with frontline chemotherapy. Another contender meanwhile also reported new data at ESMO.

Chemotherapy 75

Chemotherapy Labelling Patient Care FDA 75

The Happy PharmD

JULY 1, 2022

But consider the following: Hiring Inadequate Staff. When my wife was a patient in the hospital, there were 24 patients on her floor. During the day shift, there were 4 registered nurses (RNs) and 3 patient care technicians (PCTs). But who decided that 1 RN for every 6, 8, or 12 patients was proper staffing?

Hospitals 52

Hospitals Patient Care Chemotherapy 52

pharmaphorum

SEPTEMBER 8, 2020

Beyond significant cost savings, biosimilar uptake has been shown to simultaneously improve patient access, varying by country. A subsequent change in guidance moved this biologic to a first-line treatment, resulting in an increase in the number of patients who could receive this much-needed treatment by 104%.

Chemotherapy 99

Chemotherapy Patient Care Vaccines FDA 99

Pharmaceutical Technology

MAY 22, 2023

“The FDA approval of Epkinly represents a new treatment mechanism of action for third-line DLBCL patients. “As As a non-chemotherapy, single-agent treatment for DLBCL patients, we hope that Epkinly can effectively treat this aggressive cancer type and can be used for patient care quickly and in an off-the-shelf form for physicians.

FDA 52

FDA Adverse Reactions Chemotherapy Patient Care 52